Machine Learning

Completing a key mission 5 months early, Rocket Lab deployed novel DiskSat tech, cementing its role in the U.S. military's agile space strategy.

A top consulting firm is using AI to measure emotional intelligence, claiming it boosts profits. Is this the future of HR or a step into surveillance?

Global agency INVNT appoints its first Chief AI Officer, betting on a unique human-centric leader to navigate the AI revolution in brand storytelling.

A Utah biotech reports promising results for a novel mRNA therapy that makes cancer cells look like measles, setting the stage for crucial animal trials.

At JSHG 2025, Nabsys presents its OhmX platform, a breakthrough in electronic genome mapping that promises to solve rare disease mysteries and advance cancer research.

Early Phase 1a data for Kalaris's new nAMD drug shows significant vision improvement and potential for extended durability, aiming to reduce patient burden.

As air traffic control migrates to VoIP, new testing solutions ensure the reliability and interoperability crucial for preventing communication failures.

SCWorx Corp. has signed a new agreement with a 500-bed academic hospital, highlighting the critical need for clean data in complex Workday ERP systems.

A new report projects 27.5% annual growth for automotive AI, fueled by smart cars, government backing, and a fierce race for market dominance.

The drone taxi market is projected to soar to $3.8 billion by 2032. But can regulators, infrastructure, and public trust keep up with the hype?

EMASS's new ultra-low-power 16nm SoC integrates advanced AI and BLE, aiming to revolutionize always-on intelligence in wearables, drones, and IoT.

A $32 million contract for advanced sensors and processors will bolster U.S. armored vehicle survivability against modern battlefield threats like drones.

With social engineering attacks that trick users into copying malicious code up over 500%, a new tool aims to stop them by securing the browser itself.

A Phase 1 trial for Moleculin's WP1066 shows encouraging safety and anti-tumor activity for children with deadly brain tumors like DIPG.

New partnership launches TileDB Carrara on Snowflake, aiming to shatter data silos and accelerate breakthroughs in healthcare and life sciences.

CERo Therapeutics reports early safety success and dose escalation in its Phase 1 AML trial for CER-1236, a novel cell therapy for high-risk patients.

A €2.3M grant will help an Irish consortium develop advanced liquid cooling, tackling the immense energy demands of data centers and electric vehicles.

New data reveals a novel wound gel is successfully treating conditions previously deemed unhealable, offering hope against chronic wounds and antibiotic resistance.

Beyond the trophies, Netcracker’s four Gold Stevie awards reveal a strategic push in AI, cloud, and 5G monetization that's reshaping the telecom industry.

Armed with breakthrough data on an AI-designed therapy that penetrates the brain, Rakovina Therapeutics heads to JPM Week to court major partners.